au.\*:("SCHALK K")
Results 1 to 20 of 20
Selection :
CRYSTAL IMPRESSIONS IN DAMARA QUARTZITE, SOUTH WEST AFRICA.SCHALK K.1966; ANN. GEOL. OPNAME; MDG; 1966, VOL. 5, P. 109 A 111Miscellaneous
Geologische Geschichte des Gamsberggebietes = Evolution géologique de la Région GamsbergSCHALK, K. E. L.Journal - SWA Scientific Society. 1983, Vol 38, pp 7-15, issn 0379-6051Article
Effect of endothelin on production of cerebrospinal fluid in rabbitsSCHALK, K. A; FARACI, F. M; HEISTAD, D. D et al.Stroke (1970). 1992, Vol 23, Num 4, pp 560-563, issn 0039-2499Article
Non-invasive quantitation of liver iron-overload by magnetic resonance imagingKALTWASSER, J. P; GOTTSCHALK, R; SCHALK, K. P et al.British journal of haematology. 1990, Vol 74, Num 3, pp 360-363, issn 0007-1048, 4 p.Article
Effect of atriopeptin on blood flow to cerebrum and choroid plexusSCHALK, K. A; WILLIAMS, J. L; HEISTAD, D. D et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1989, Vol 26, Num 6, pp R1365-R1369, issn 0363-6119Article
Bibliography of South West African/Namibian earth science = Bibliographie des sciences de la terre: Sud Ouest Africain/NamibieHUGO, P. J; SCHALK, K. E. L; BARNES, Sarah Jane et al.1983, 142 p., isbn 0-620-06539-7Book
Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemiaKALTWASSER, J. P; DIX, U; SCHALK, K. P et al.European journal of haematology. 1988, Vol 40, Num 2, pp 111-118, issn 0902-4441Article
Cerebral blood flow during fastigial pressor response in catsWILLIAMS, J. L; MURRAY, M. A; SCHALK, K. A et al.American journal of physiology. Heart and circulatory physiology. 1990, Vol 27, Num 3, pp H729-H733, issn 0363-6135Article
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosisKALTWASSER, J. P; WERNER, E; SCHALK, K et al.Gut. 1998, Vol 43, Num 5, pp 699-704, issn 0017-5749Article
Effect of atriopeptin on production of cerebrospinal fluidSCHALK, K. A; FARACI, F. M; WILLIAMS, J. L et al.Journal of cerebral blood flow and metabolism. 1992, Vol 12, Num 4, pp 691-696, issn 0271-678XArticle
Stimulation of area postrema decreases blood flow to choroid plexusWILLIAMS, J. L; THEBERT, M. M; SCHALK, K. A et al.American journal of physiology. Heart and circulatory physiology. 1991, Vol 29, Num 3, pp H902-H908, issn 0363-6135Article
Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogsTOMANEK, R. J; SCHALK, K. A; MARCUS, M. L et al.Circulation research. 1989, Vol 65, Num 2, pp 352-359, issn 0009-7330Article
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadismCAZZOLA, M; ASCARI, E; BAROSI, G et al.Human genetics. 1983, Vol 65, Num 2, pp 149-154, issn 0340-6717Article
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphomaRUMMEL, M. J; CHOW, K. U; BERGMANN, L et al.European journal of cancer (1990). 2002, Vol 38, Num 13, pp 1739-1746, issn 0959-8049Article
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-bleo and CHOPSTEINKE, B; BROSS, K; ZWINGERS, T et al.European journal of cancer (1990). 1992, Vol 28, Num 1, pp 100-104, issn 0959-8049Conference Paper
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy : A study of the German Hodgkin's lymphoma study groupTESCH, H; DIEHL, V; SCHWIEDER, G et al.Blood. 1998, Vol 92, Num 12, pp 4560-4567, issn 0006-4971Article
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialSIEBER, M; TESCH, H; ROLLER, S et al.Annals of oncology. 2004, Vol 15, Num 2, pp 276-282, issn 0923-7534, 7 p.Article
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study GroupDIEHL, V; PFREUNDSCHUH, M; BARTELS, H et al.Medical oncology and tumor pharmacotherapy. 1989, Vol 6, Num 2, pp 155-162, issn 0736-0118Article
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's diseaseDIEHL, V; LOEFFLER, M; ADLER, M et al.Annals of oncology. 1995, Vol 6, Num 9, pp 901-910, issn 0923-7534Article
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's diseaseLOEFFLER, M; DIEHL, V; BARTELS, H et al.Journal of clinical oncology. 1997, Vol 15, Num 6, pp 2275-2287, issn 0732-183XArticle